关于奕瑞电子科技集团股份有限公司 使用暂时闲置募集资金进行现金管理事项的核查意见 中国国际金融股份有限公司 中国国际金融股份有限公司（以下简称"保荐机构"）作为奕瑞电子科技集团股份有 限公司（以下简称"奕瑞科技"或"公司"）的保荐机构，根据《证券发行上市保荐业务管 理办法》《上市公司募集资金监管规则》《上海证券交易所科创板股票上市规则》《上 海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》等有关法律、行政法 规、部门规章及业务规则的要求，对奕瑞电子科技集团股份有限公司本次使用暂时闲置 募集资金进行现金管理的事项进行了认真、审慎核查，具体情况如下： 一、募集资金基本情况 （一）实际募集资金金额、资金到账情况 1、2020 年公司首次公开发行股票募集资金情况 根据中国证券监督管理委员会（以下简称"中国证监会"）于 2020 年 8 月 18 日出 具的《关于同意上海奕瑞光电子科技股份有限公司首次公开发行股票注册的批复》（证 监许可[2020]1823 号），同意公司首次公开发行股票的注册申请。 公司首次公开发行人民币普通股（A 股）1,820.00 万股，每股发行价格为人民币 119.60 元，募集 ...

| 证券代码：688301 | 证券简称：奕瑞科技 | 公告编号：2025-055 | | --- | --- | --- | | 转债代码：118025 | 转债简称：奕瑞转债 | | 奕瑞电子科技集团股份有限公司 2025 年半年度募集资金存放与实际使用情况的专项 报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 根据《上市公司募集资金监管规则》《上海证券交易所科创板上市公司自律 监管指引第 1 号——规范运作》和《上海证券交易所科创板股票上市规则》等有 关规定，现将奕瑞电子科技集团股份有限公司（以下简称"公司"）2025 年半 年度募集资金存放与实际使用情况报告如下： 一、募集资金基本情况 （一）实际募集资金金额、资金到账情况 1、2020 年公司首次公开发行股票募集资金情况 经中国证券监督管理委员会出具的《关于同意上海奕瑞光电子科技股份有限 公司首次公开发行股票注册的批复》（证监许可[2020]1823 号）同意，公司首次 公开发行人民币普通股（A 股）1,820 万股，每股发行价格人民币 119.60 元，募 ...

奕瑞科技8月15日晚间公告，公司上半年实现营业收入10.67亿元，同比增长3.94%；归属于上市公司股 东的净利润3.35亿元，上年同期3.07亿元，同比增长8.82%；基本每股收益1.67元。经营活动产生的现金 流量净额增加，主要系收到客户支付履约保证金，以及销售回款增加所致。 ...

Market Overview - The market continues its upward trend with all three major indices reaching new highs for the year, with the Shanghai Composite Index achieving a seven-day winning streak and peaking at 3669.04 points [1] - A-shares saw a total trading volume of 1.91 trillion yuan, marking a significant increase in market activity over the past two days [1] Technology Sector - The technology growth sector is thriving, with significant gains in various ETFs, particularly those focused on AI and hard technology [1] - The AI sector is highlighted as a key focus, with stocks like Cambricon Technologies hitting the daily limit and achieving historical highs in trading volume and price [1] - The Huabao Entrepreneurial AI ETF (159363) surged by 3.03%, reaching a new listing high, reflecting strong investor interest [1][4] Financial Sector - The financial sector is also performing well, with brokerage stocks leading the charge, as evidenced by Guosheng Financial Holdings hitting the daily limit [2] - The top-performing brokerage ETF (512000) experienced high-frequency premiums, indicating strong market confidence [2] - Bank stocks are recovering, with Agricultural Bank of China achieving new highs for six consecutive days [2] AI and Cloud Computing - Positive news in the AI sector includes Huawei's announcement of a breakthrough in AI inference technology, which is expected to accelerate AI application growth [6][13] - The capital expenditure of major cloud companies is projected to exceed $330 billion by 2025, indicating robust growth in the AI and cloud computing sectors [6] - The entrepreneurial AI index has seen a cumulative increase of nearly 35% this year, outperforming other AI indices [6] Investment Opportunities - Analysts recommend focusing on the "AI main line" investment opportunities, particularly in the AI application and computing power sectors [8] - The domestic semiconductor industry is expected to benefit from increased demand for AI chips, driven by the need for domestic alternatives amid rising geopolitical tensions [13][14] - The medical sector is also gaining traction, with significant interest in brain-computer interface technologies and related stocks [15][17] ETF Performance - The Huabao Entrepreneurial AI ETF (159363) has become the largest in its category, with a trading volume of 2.67 billion yuan, reflecting high market activity [4][18] - The Huabao Sci-Tech AI ETF (589520) also performed well, with a peak increase of 3.12% during trading [9][14] Key Developments - The upcoming release of DeepSeek-R2 is generating excitement in the market, with expectations of significant advancements in AI capabilities [11] - The Ministry of Industry and Information Technology has outlined plans to promote the development of brain-computer interface technologies, indicating a growing focus on this innovative sector [17]

| 证券代码：688301 | 证券简称：奕瑞科技 公告编号：2025-051 | | --- | --- | | 转债代码：118025 | 转债简称：奕瑞转债 | 奕瑞电子科技集团股份有限公司 关于不向下修正"奕瑞转债"转股价格的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 根据中国证券监督管理委员会关于可转换公司债券发行的有关规定和《上海 奕瑞光电子科技股份有限公司向不特定对象发行可转换公司债券募集说明书》 （以下简称"《募集说明书》"）的约定，公司发行的"奕瑞转债"自 2023 年 4 月 28 日起可转换为本公司股份，初始转股价格为 499.89 元/股。 1 因公司 2021 年限制性股票激励计划首次授予部分第一个归属期归属登记， "奕瑞转债"转股价格从 499.89 元/股调整为 499.26 元/股。具体内容详见公司于 2023 年 3 月 11 日在上海证券交易所网站（www.sse.com.cn）披露的《上海奕瑞 光电子科技股份有限公司关于"奕瑞转债"转股价格调整的公告》（公告编号： 2023- ...

| 证券代码：688301 | 证券简称：奕瑞科技 | 公告编号：2025-050 | | --- | --- | --- | | 转债代码：118025 | 转债简称：奕瑞转债 | | 奕瑞电子科技集团股份有限公司 关于"奕瑞转债"预计满足转股价格修正条件的 提示性公告 二、可转债转股价格修正条款与可能触发情况 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、可转债发行上市概况 经中国证券监督管理委员会《关于同意上海奕瑞光电子科技股份有限公司向 不特定对象发行可转债注册的批复》（证监许可[2022]2167 号）同意注册申请， 奕瑞电子科技集团股份有限公司（以下简称"公司"）向不特定对象共计发行 14,350,100 张可转换公司债券，每张面值为人民币 100 元，按面值发行。本次发 行可转债募集资金总额为人民币 143,501.00 万元；扣除发行费用（不含增值税） 人民币 1,369.65 万元后，募集资金净额为人民币 142,131.35 万元，上述资金已全 部到位，经立信会计师事务所（特殊普通合伙）审验并于 ...

Group 1 - The medical device industry experienced a decline of 0.17% on July 29, with a net outflow of 351 million yuan in main funds, where 55 stocks rose and 43 fell [1] - The companies with the highest net outflow of main funds included Yirui Technology (14.03 million yuan), Meihao Medical (13.99 million yuan), Aohua Endoscopy (13.90 million yuan), Kangzhong Medical (13.42 million yuan), and Microelectrophysiology (12.50 million yuan) [1] Group 2 - Notable stock performance included BGI Genomics with a price of 53.69 and a rise of 3.17%, attracting a net inflow of 745.64 million yuan, representing 10.25% of the main fund [2] - Other companies with significant movements included Nanwei Medical, which fell by 1.27% to 84.08, with a net inflow of 535.99 million yuan (11.35%); Sanofi Biological, which dropped by 6.62% to 21.44, with a net inflow of 507.66 million yuan (6.33%); and Haooubo, which rose by 2.86% to 124.82, with a net inflow of 426.62 million yuan (18.96%) [2]

Core Viewpoint - Tianjin Sequoia and Beijing Sequoia plan to reduce their holdings in Yirui Technology by up to 4.0044 million shares, representing no more than 2% of the total shares, due to their own funding needs [1][2] Group 1: Shareholding and Reduction - The total amount from the maximum reduction is approximately 351 million yuan, based on the closing price of 87.99 yuan per share on the announcement date [1] - As of the announcement date, Tianjin Sequoia and Beijing Sequoia hold 11.7859 million shares and 5.5473 million shares of Yirui Technology, accounting for 5.89% and 2.77% of the total share capital, respectively [2] - The Sequoia group has been invested in Yirui Technology for thirteen years, participating in A and B round financing in 2012 and 2014 [1] Group 2: Historical Performance and Market Trends - Yirui Technology's stock price has been weak, with a decline of over 10% year-to-date, and the stock price was reported at 85.3 yuan per share, with a total market value of approximately 17.08 billion yuan [2] - The company’s revenue for 2022 to 2024 is reported as 1.549 billion yuan, 1.864 billion yuan, and 1.831 billion yuan, while the net profit attributable to shareholders is 641 million yuan, 607 million yuan, and 465 million yuan, respectively [2] - In the first quarter of 2025, Yirui Technology's revenue was 482 million yuan, showing a year-on-year decline of 1.92%, while the net profit attributable to shareholders was 143 million yuan, reflecting a year-on-year growth of 2.74% [2]

Group 1 - Zhongyuan Tong plans to establish a joint venture with Zhengzhou Zhengfang Technology with a registered capital of 10 million yuan, where Zhongyuan Tong will contribute 5.1 million yuan for a 51% stake [1] - Weiguang Co. reported a net profit of 172 million yuan for the first half of 2025, representing a year-on-year increase of 11.32%, with total revenue reaching 750 million yuan, up 10% [1] - Tianlu Technology's actual controller plans to reduce his stake by up to 2%, amounting to 220,640 shares [1][2] Group 2 - Igor received approval from the China Securities Regulatory Commission for a stock issuance to specific investors, valid for 12 months [2] - Hualing Cable also received approval from the China Securities Regulatory Commission for a similar stock issuance [2] - Hongchang Technology's employee stockholding platform plans to reduce its stake by up to 2.56%, equating to 331,630 shares [3][4] Group 3 - Saiyi Information intends to invest 10 million yuan in Douma Technology to acquire a 3.23% stake [5] - Meino Biological's major shareholder plans to reduce his stake by up to 1%, which is 140,780 shares [5] - New Light Optoelectronics' shareholder plans to reduce his stake by up to 3%, totaling 3 million shares [6] Group 4 - Shenzhen Energy plans to invest 7.897 billion yuan in the construction of the Shantou Honghaiwan offshore wind power project, with 1.581 billion yuan from its own funds [7][8] - Zhongqi Co. plans to reduce its stake by up to 3%, which amounts to 39,717,000 shares [9] - Yirui Technology's two shareholders plan to reduce their combined stake by up to 2%, equating to 400,440 shares [11] Group 5 - Wenkai Co. is planning debt restructuring involving approximately 2.22 billion yuan in receivables and 1.24 billion yuan in cash payments [12] - Guangnong Sugar's application for a stock issuance to specific investors has been approved by the Shenzhen Stock Exchange [13] - Dalian Shengya is planning a stock issuance that may lead to a change in control, resulting in continued trading suspension [15] Group 6 - ST Saiwei has received a court decision for pre-restructuring and appointed a management team for the process [18] - Gaozheng Minexplosion's major shareholder reduced his stake by 128,100 shares during a period of stock price fluctuation [19] - Zhongfu Information's chairman has been detained, with responsibilities temporarily assigned to the deputy general manager [20] Group 7 - Huayu Mining plans to adjust the valuation of its 40% stake in Guizhou Yatai Mining and acquire an additional 11% stake for a total transaction value of 809 million yuan [21] - ST Jinbi intends to invest 50 million yuan in Cangqiong Digital, acquiring a 2.56% stake [23] - Xinxing Casting is planning to publicly transfer its 51% stake in Xinjiang Mining with a starting price of 205 million yuan [25]

Group 1 - The core point of the article is that Sequoia Capital has initiated a share reduction plan for Yirui Technology, which is known as the "first stock of digital X-ray detectors" [1][2] - Sequoia Capital's Tianjin and Beijing branches currently hold a combined 17.33 million shares of Yirui Technology, representing 8.66% of the total share capital [1] - The planned reduction involves selling up to 4.0044 million shares, which is no more than 2% of the total share capital, potentially generating approximately 350 million yuan based on the current share price [1][2] Group 2 - Yirui Technology is a supplier of digital X-ray core components and comprehensive solutions, with applications in medical, dental, radiotherapy, veterinary, and industrial fields [2] - The company's performance has been under pressure, with a revenue decline of 1.74% year-on-year to 1.831 billion yuan in 2024, and a net profit drop of 25.84% to 439 million yuan [2] - In the first quarter of 2025, Yirui Technology reported a revenue of 482 million yuan, down 1.92% year-on-year, and a net profit of 141 million yuan, down 9.19% year-on-year [2]